Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells

Environmental and Molecular Mutagenesis

Volumn 40, Issue 4, 2002, Pages 266-276

  Snyder, Ronald D ^a   Gillies, Peter J ^a  

^a Bristolamyers Squibb Pharma Company   (United States)

Author keywords

Bleomycin amplification; Flavonoids; Intercalation; Reactive oxygen species; Topoisomerase

Indexed keywords

ACACETIN; APIGENIN; BAICALEIN; BIOFLAVONOID; BLEOMYCIN; CLASTOGEN; COPPER COMPLEX; DAIDZEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); FISETIN; GALANGIN; GENISTEIN; GYRASE INHIBITOR; HESPERETIN; INTERCALATING AGENT; LUTEOLIN; MANGANESE DERIVATIVE; MYRICETIN; NARINGENIN; POLYPHENOL; QUERCETIN; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TAXIFOLIN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CHO CELL; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; GENOTOXICITY; INTERCALATION COMPLEX; NONHUMAN; STRUCTURE ACTIVITY RELATION;

CRICETINAE; CRICETULUS GRISEUS; EUKARYOTA; PROKARYOTA;

EID: 0036938075     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10121     Document Type: Article

References (51)

1. Afanas'Ev IB, Dorozhko AI, Brodskii AV, Kostyuk A, Potopovitch AI. 1989. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38:1763-1769.
2. Ahmed MS, Ramesh V, Nagaraja V, Parish JH, Hadi SM. 1994. Mode of binding of quercetin to DNA. Mutagenesis, 9:193-197.
3. Asad SF, Singh S, Ahmad A, Hadi SM. 1998. Flavonoids: antioxidants in diet and potential anticancer agents. Med Sci Res 26:723-728.
4. Austin CA, Patel S, Ono K, Nakane H, Fisher LM. 1992. Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J 282:883-889.
5. Bjeldanes F, Chang GW. 1977. Mutagenic activity of quercetin and related compounds. Science 197:577-578.
6. Boege F, Straub T, Kehr A, Boesenberg C, Christiansen K, Andersen A, Jakob F, Kohrle J. 1996. Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J Biol Chem 271:2262-2270.
7. Boos G, Stopper H. 2000. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol Lett 116:7-16.
8. Brown JE, Khodr H, Hider RC, Rice-Evans CA. 1998. Structural dependence of flavonoid interactions with Cu-2+ ions: implications for their antioxidant properties. Biochem J 330:1173-1178.
9. Cain BF, Baguley BC, Denny WA. 1978. Potential antitumor agents. 28. Deoxyribonucleic acid polyintercalating agents. J Med Chem 21:658-688.
10. Constantinou A, Mehta, R, Runyan C, Rao K, Vaughan A, Moon R. 1995. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod 58:217-225.
11. Duthie SJ, Johnson W, Dobson VL. 1997. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mutat Res 390:141-1541.
12. Edwards ML, Snyder RD, Stemerick DM. 1991. Synthesis and DNA binding properties of polyamine analogs. J Med Chem 34:2414-2420.
13. Fenech M, Morley AA. 1985. Measurement of micronuclei in human lymphocytes. Mutat Res 147:29-36.
14. Franz CE, Chen H, Eastmond DA. 1996. Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. Environ Health Perspect 104:1319-1323.
15. Gaspar J, Rodrigues A, Laires A, Silva F, Costa S, Monteiro MJ, Monteiro C, Rueff J. 1994. On the mechanisms of genotoxicity and metabolism of quercetin. Mutagenesis 9:445-449.
16. Havsteen B. 1983. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141-1148.
17. Heo MY, Sohn SJ, Au WW. 2001. Antigenotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat Res 488:135-150.
18. Hodnick WF, Kung FS, Roettger WA, Bohmont CW, Pardini RS. 1986. Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. Biochem Pharmacol 35:2345-2357.
19. Hutt AM, Kalf GF. 1996. Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene. Environ Health Perspect 104:1265-1269.
20. Ishida R, Iwai M, Hara A, Andoh T. 1996. The combination of different types of antitumor topoisomerase II inhibitors, ICRF-193 and VP-16, has synergistic and antagonistic effects on cell survival, depending on treatment schedule. Anticancer Res 16:2735-2740.
21. Jensen PB, Sehested M. 1997. DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide. Biochem Pharmacol 54:755-759.
22. Jensen PB, Sorensen BS, Sehested M, Demant EGF, Koeldsen E, Friche E, Hansen HH. 1993. Different modes of anthracycline interaction with topoisomerase II: separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance. Biochem Pharmacol 45:2025-2035.
23. Jensen PB, Sorensen BS, Sehested M, Grue P, Demant EJF, Hansen HH. 1994. Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments. Cancer Res 54:2959-2963.
24. Ju R, Mao Y, Glick MJ, Muller MT, Snyder RD. 2001. Catalytic inhibition of DNA topoisomerase II alpha by sodium azide. Toxicol Lett 121:119-126.
25. Kuo S-M, Leavitt PS, Lin C-P. 1998. Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells. Biol Trace Elem Res 62:135-153.
26. MacGregor JT, Wehr CM, Manners GD, Jurd L, Minkler JL, Carrano AV. 1983. In vivo exposure to plant flavonols. Influence on frequencies of micronuclei in mouse erythrocytes and sister-chromatid exchange in rabbit lymphocytes. Mutat Res 124:255-270.
27. Marzano C, Severin E, Falcomer S, Chilin A, Bordin F. 1999. Cell killing and DNA damage induced in cultured mammalian cells by some tetrahydrobenzopsoralenquinones. Mutat Res 438:133-143.
28. Moon JY, Lee DW, Park KH. 1998. Inhibition of 7-ethoxycoumarin O-deethylase activity in rat liver microsomes by naturally occurring flavonoids: structure-activity relationships. Xenobiotica 28:117-126.
29. Morris SK, Lindsley JE. 1999. Yeast topoisomerase II is inhibited by etoposide after hydrolyzing the first ATP and before releasing the second ADP. J Biol Chem 274:30690-30696.
30. Neder K, Marton LJ, Liu LF, Frydman, B. 1998. Reaction of beta-lapachone and related naphthoquinones with 2-mercaptoethanol: a biomimetic model of topoisomerase II poisoning by quinones. Cell Mol Biol 44:465-474.
31. Pommier Y, Minford JK, Schwartz RE, Zwelling LA, Kohn KW. 1985. Effects of the DNA intercalators 4′-(9-acridinylamino)methanesulfona-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage. Biochemistry 24:6410-6416.
32. Robinson MJ, Corbett AH, Osheroff N. 1993. Efects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II. Biochemistry 32:3638-3643.
33. Rowe T, Kupfer G, Ross WE. 1985. Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage. Biochem Pharmacol 34:2483-2487.
34. Sahu RK, Basu R, Sharma A. 1981. Genetic toxicological testing of some plant flavonoids by the micronucleus test. Mutat Res 89:69-74.
35. Silva ID, Gaspar J, Gomes da Costa G, Rodrigues AS, Laires A, Rueff J. 2000. Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents. Chem-Biol Interact 124:29-51.
36. Snyder RD. 1998. A review and investigation into the mechanistic basis of the genotoxicity of antihistamines. Mutat Res 411:235-248.
37. Snyder RD. 2000. Use of catalytic topoisomerase inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells. Environ Mol Mutagen 35:13-21.
38. Snyder RD, Arnone MR. 2002. Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutat Res 503:21-35.
39. Snyder RD, Diehl MS. 2000. The bleomycin amplification assay in V79 cells predicts frameshift mutagenicity of intercalative agents. Mutagenesis 15:203-205.
40. Snyder RD, Friedman MB. 1998. Enhancement of cytotoxicity and clastogenicity of L-DOPA and dopamine by manganese and copper. Mutat Res 405:1-8.
41. Snyder RD, Grdina DJ. 2000. Further evidence that the radioprotective aminothiol, WR1065, catalytically inactivates mammalian topoisomerase II. Cancer Res 60:1186-1188.
42. Snyder RD, Strekowski L. 1999. Enhancement of bleomycin-induced micronucleus formation in V79 cells as a rapid and sensitive screen for non-covalent DNA binding compounds. Mutat Res 444:181-192.
43. Solimani R, Bayon F, Domini I, Pifferi PG, Todesco PE, Marconi G, Samori B. 1995. Flavonoid-DNA interaction studied with flow linear dichroism technique. J. Agric Food Chem 43:876-882.
44. Stich HF, Rosin MP, Wu CH, Powrie WD. 1981. The action of transition metals on the genotoxicity of simple phenols, phenolic acids and cinnamic acids. Cancer Lett 14:251-260.
45. Strekowski L. 1992. Molecular basis for the enhancement and inhibition of bleomycin-mediated degradation of DNA by DNA-binding compounds. Adv Detail React Mech 2:61-109
46. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. 2000. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 97:4790-4795.
47. Wang H, Joseph JA. 1999. Quantifying cellular oxidative stress by diclorofluorescein assay using microplate reader. Free Rad Biol Med 27:612-616.
48. Yamashita N, Kawanishi S. 2000. Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin. Free Radic Res 33:623-633.
49. Yamashita Y, Kawada S-Z, Nakano H. 1990. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 39:737-744.
50. Yamashita N, Tanemura H, Kawanishi S. 1999. Mechanism of oxidative DNA damage induced by quercetin in the presence of Cu(II). Mutat Res 425:107-115.
51. Zhai S, Dai R, Friedman FK, Vestal RE. 1998. Comparative inhibition of human cytochromes p450 1a1 and 1a2 by flavonoids. Drug Metab Dispos 26:989-992.